Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma.

Nat Med 2015 Oct 21;21(10):1163-71. Epub 2015 Sep 21.

Second Department of Internal Medicine, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal human cancers and shows resistance to any therapeutic strategy used. Here we tested small-molecule inhibitors targeting chromatin regulators as possible therapeutic agents in PDAC. We show that JQ1, an inhibitor of the bromodomain and extraterminal (BET) family of proteins, suppresses PDAC development in mice by inhibiting both MYC activity and inflammatory signals. The histone deacetylase (HDAC) inhibitor SAHA synergizes with JQ1 to augment cell death and more potently suppress advanced PDAC. Finally, using a CRISPR-Cas9-based method for gene editing directly in the mouse adult pancreas, we show that de-repression of p57 (also known as KIP2 or CDKN1C) upon combined BET and HDAC inhibition is required for the induction of combination therapy-induced cell death in PDAC. SAHA is approved for human use, and molecules similar to JQ1 are being tested in clinical trials. Thus, these studies identify a promising epigenetic-based therapeutic strategy that may be rapidly implemented in fatal human tumors.

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm.3952DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959788PMC
October 2015
164 Reads

Publication Analysis

Top Keywords

cell death
8
ductal adenocarcinoma
8
pancreatic ductal
8
therapeutic strategy
8
bet family
8
family proteins
8
pdac
5
cdkn1c combined
4
de-repression p57
4
development mice
4
myc activity
4
p57 kip2
4
combined bet
4
inhibiting myc
4
kip2 cdkn1c
4
mice inhibiting
4
suppresses pdac
4
required induction
4
inhibitor bromodomain
4
jq1 inhibitor
4

References

(Supplied by CrossRef)

L Rahib et al.
Cancer Res. 2014

AF Hezel et al.
Genes Dev. 2006

P Ghaneh et al.
Gut 2007

A Maitra et al.
Annu. Rev. Pathol. 2008

DP Ryan et al.
N. Engl. J. Med. 2014

MA Collins et al.
Frontiers Physiol. 2013

JR Infante et al.
Eur. J. Cancer 2014

N Bardeesy et al.
Nat. Rev. Cancer 2002

AV Biankin et al.
Nature 2012

N Waddell et al.
Nature 2015

N Bardeesy et al.
Proc. Natl. Acad. Sci. USA 2006

Similar Publications